Bio Green Med Solution Inc Preferred Stock
BGMSP
BGMSP was delisted on the 20th of March, 2026.
1 hedge funds and large institutions have $12K invested in Bio Green Med Solution Inc Preferred Stock in 2018 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
0.39% less ownership
Funds ownership: 1.07% → 0.68% (-0.39%)
40% less capital invested
Capital invested by funds: $20K → $12K (-$8K)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$829 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$9K |
BGMSP Hedge Fund Activity: Q4 2018 in Review
1 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Bio Green Med Solution Inc Preferred Stock (BGMSP) for Q4 2018, worth a combined $12K — down 40% from $20K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BGMSP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $829. The largest seller was Citigroup, exiting entirely with an estimated $9K sold.
- 1 institutional investor held Bio Green Med Solution Inc Preferred Stock (BGMSP) as of Q4 2018, down from 2 in Q3 2018.
- Funds reported $12K of Bio Green Med Solution Inc Preferred Stock stock for Q4 2018, down 40% quarter-over-quarter.
- 0 funds opened new Bio Green Med Solution Inc Preferred Stock positions in Q4 2018 and 1 closed out, a net change of -1 holder.
- The largest Bio Green Med Solution Inc Preferred Stock buyer in Q4 2018 was UBS Group, an estimated $829 added.
- The largest Bio Green Med Solution Inc Preferred Stock seller in Q4 2018 was Citigroup, an estimated $9K sold.
Based on aggregated 13F filings for Q4 2018.